inclusion criteria: 1. between 18 and 65 years of age, inclusive at time of signing the icf. 2. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.

inclusion criteria: 1. between 18 and 65 years of age, inclusive at time of signing the icf. 2. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.

inclusion criteria: between 18 and 65 years of age, inclusive at time of signing the icf. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.

inclusion criteria: between 18 and 65 years of age, inclusive at time of signing the icf. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.

inclusion criteria: 1. between 18 and 65 years of age, inclusive at time of signing the icf. 2. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.

inclusion criteria: 1. between 18 and 65 years of age, inclusive at time of signing the icf. 2. subjects with low to moderate risk defined as news covid-19 infection as confirmed by reverse transcriptase polymerase chain reaction (rt-pcr) assay 72 hours prior to clinical trial enrollment.